Cellador Pty Ltd

Status: Registered
Australian Company Number: 000200448
Australian Business Number: 68000200448
Registration date: Friday 3rd May 1957
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Cellador Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2088 since 2000-03-06 the company is, as the updated on 2002-05-09 ABN database shows, registered. Known company numbers for Cellador Pty Ltd are as follows: ACN - 000200448, Australian Business Number - 68000200448. Their official company name changed on 2001-12-11 to Cellador Pty Limited. The company had used this name up until 2002-05-09. Additionally they had used Cellador Pty Limited As Trustee For The Ryan Family Trust from 2000-03-06 to 2001-12-11.

Details for ABN 68000200448

Type: Australian Private Company

ABN Status

Status From To
Active Monday 6th March 2000 current

Main Name

Name From To
Cellador Pty Ltd Thursday 9th May 2002 current
Cellador Pty Limited Tuesday 11th December 2001 Thursday 9th May 2002
Cellador Pty Limited As Trustee For The Ryan Family Trust Monday 6th March 2000 Tuesday 11th December 2001

Main Location

Location From To
NSW 2088 Monday 6th March 2000 current

Advertisements

Find company

NSW 2088 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.